Biogen Idec, Inc. et al v. Glaxosmithkline LLC et al > Summary
Court Case Number 3:10-cv-00608
Filing Date Mar 24, 2010
Termination Date Nov 15, 2011
Court California Southern District Court
Status Judgment - Motion Before Trial
Plaintiff Attorneys
8Biogen
Attorney Name: John Allcock
DLA Piper
Genentech, Inc
Attorney Name: John Allcock
DLA Piper
Biogen
Attorney Name: Erica J. Pascal
DLA Piper
Genentech, Inc
Attorney Name: Erica J. Pascal
DLA Piper
Biogen
Attorney Name: Stuart E. Pollack
DLA Piper
Genentech, Inc
Attorney Name: Stuart E. Pollack
DLA Piper
Biogen
Attorney Name: Kathryn Riley Grasso
DLA Piper
Genentech, Inc
Attorney Name: Kathryn Riley Grasso
DLA Piper
Defendant Attorneys
16Glaxo Group Limited
Attorney Name: Lisa M. Ferri
Mayer Brown
GlaxoSmithKline
Attorney Name: Lisa M. Ferri
Mayer Brown
Glaxo Group Limited
Attorney Name: Robert M. Galvin
Howrey LLP
GlaxoSmithKline
Attorney Name: Robert M. Galvin
Howrey LLP
Glaxo Group Limited
Attorney Name: Andrea C. Hutchison
Mayer Brown
GlaxoSmithKline
Attorney Name: Andrea C. Hutchison
Mayer Brown
Glaxo Group Limited
Attorney Name: Elizabeth D. Mann
Mayer Brown
GlaxoSmithKline
Attorney Name: Elizabeth D. Mann
Mayer Brown
Glaxo Group Limited
Attorney Name: Richard J. McCormick
Mayer Brown
GlaxoSmithKline
Attorney Name: Richard J. McCormick
Mayer Brown
Glaxo Group Limited
Attorney Name: Vera A. Nackovic
Mayer Brown
GlaxoSmithKline
Attorney Name: Vera A. Nackovic
Mayer Brown
Glaxo Group Limited
Attorney Name: Brian W. Nolan
Mayer Brown
GlaxoSmithKline
Attorney Name: Brian W. Nolan
Mayer Brown
Glaxo Group Limited
Attorney Name: Henry C. Su
Federal Trade Commission
GlaxoSmithKline
Attorney Name: Henry C. Su
Federal Trade Commission
Counter Defendant
6Biogen
Attorney Name: John Allcock
DLA Piper
Genentech, Inc
Attorney Name: John Allcock
DLA Piper
Biogen
Attorney Name: Erica J. Pascal
DLA Piper
Genentech, Inc
Attorney Name: Erica J. Pascal
DLA Piper
Biogen
Attorney Name: Kathryn Riley Grasso
DLA Piper
Genentech, Inc
Attorney Name: Kathryn Riley Grasso
DLA Piper
Counter Claimant
16Glaxo Group Limited
Attorney Name: Lisa M. Ferri
Mayer Brown
GlaxoSmithKline
Attorney Name: Lisa M. Ferri
Mayer Brown
Glaxo Group Limited
Attorney Name: Robert M. Galvin
Howrey LLP
GlaxoSmithKline
Attorney Name: Robert M. Galvin
Howrey LLP
Glaxo Group Limited
Attorney Name: Andrea C. Hutchison
Mayer Brown
GlaxoSmithKline
Attorney Name: Andrea C. Hutchison
Mayer Brown
Glaxo Group Limited
Attorney Name: Elizabeth D. Mann
Mayer Brown
GlaxoSmithKline
Attorney Name: Elizabeth D. Mann
Mayer Brown
Glaxo Group Limited
Attorney Name: Richard J. McCormick
Mayer Brown
GlaxoSmithKline
Attorney Name: Richard J. McCormick
Mayer Brown
Glaxo Group Limited
Attorney Name: Vera A. Nackovic
Mayer Brown
GlaxoSmithKline
Attorney Name: Vera A. Nackovic
Mayer Brown
Glaxo Group Limited
Attorney Name: Brian W. Nolan
Mayer Brown
GlaxoSmithKline
Attorney Name: Brian W. Nolan
Mayer Brown
Glaxo Group Limited
Attorney Name: Henry C. Su
Federal Trade Commission
GlaxoSmithKline
Attorney Name: Henry C. Su
Federal Trade Commission
Cause
35:0145 Civil Action to Obtain Patent
Related Patents
Doc No | Title | Issue date |
---|---|---|
07682612 | Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody | Mar 23, 2010 |